Development of Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia during Treatment with Nilotinib

We report on a patient diagnosed with chronic myeloid leukemia (CML) who developed myasthenia gravis while on treatment with nilotinib. Autoimmune disease, including the development of myasthenia gravis, has been described in association with CML as well as the use of tyrosine kinase inhibitors. Sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanford, David, MacDonald, Maria, Nicolle, Michael, Xenocostas, Anargyros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091286/
https://www.ncbi.nlm.nih.gov/pubmed/25013714
http://dx.doi.org/10.4081/hr.2014.5288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091286/
https://www.ncbi.nlm.nih.gov/pubmed/25013714
http://dx.doi.org/10.4081/hr.2014.5288

Ejemplares similares